Neurona Therapeutics
Building the next generation of cell-based medicines
116 employees · est. 2008 · South San Francisco, United...
Thymmune Therapeutics
Biotech firm developing thymic cell therapies to restore immune function using machine learning
26 employees · est. 2019 · Cambridge, United States
Neurona Therapeutics is the older company (2008 vs 2019); Neurona Therapeutics is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Neurona Therapeutics | Thymmune Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2019 |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Cambridge, United States |
| Employees | ||
| Employees | 116 larger | 26 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Acquired | Seed |
| Total Funding | ||
| Total Funding | $966.54M | $44.30M |
| Funding Rounds | ||
| Funding Rounds | 11 | 3 |
| Services | ||
| Services | Development of regenerative cell therapies, Clinical-stage biotherapeutics R&D, Therapeutic pipeline management, Neural circuitry integration | Development of thymic cell engineering platform, Mass production of iPSC-derived thymic cells, Research and development of therapies for immune disorders, Preclinical studies of thymic cell therapy, Therapeutic development for healthy immune aging |
| Target Customers | ||
| Target Customers | Patients with chronic neurological disorders, Healthcare providers, Clinical researchers, Medical professionals specialized in neurology | Patients with immune-mediated diseases, Individuals with immunodeficiencies, Patients experiencing age-related immune decline, Healthcare professionals seeking innovative treatments |
| Taxonomy | ||
| Taxonomy | Biotherapeutics, Neural Cell Therapies, Chronic Neurological Disorders, Regenerative Platform, Neuronal Cell Therapy, Glial Cell Therapy, Gene-edited Cell Therapy, Neural Cell Lineage, Single-dose Curative Potential, Dysfunctional Neural Networks, Neurological Disorders, Cell-based Medicines | Thymic Cell Therapies, IPSC Manufacturing, Immunotherapy, Immune Restoration, Aging, Disease Treatment, Immunodeficiencies, Transplant Therapeutics, Autoimmune Diseases, Cell Engineering, Off-the-shelf Therapies, Therapeutic Pipeline, Biotech Innovation |
| Website | ||
| Website | neuronatherapeutics.com | thymmune.com |
About Neurona Therapeutics
Neurona Therapeutics, a pioneering entity in the Biotechnology and Health Care sectors, is transforming the landscape of cell-based medicines. Established in 2008, Neurona is at the forefront of developing neural cell therapies with the potential for a one-time cure of chronic neurological disorders...
About Thymmune Therapeutics
Thymmune Therapeutics, a Cambridge, MA-based biotech firm, is pioneering in the realm of thymic cell therapies with an innovative use of machine learning to restore immune function. Founded in 2019, the company focuses on developing a unique platform that utilizes iPSC-thymic cell manufacturing to p...
We will tell you when either one moves
BounceWatch watches Neurona Therapeutics and Thymmune Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Neurona Therapeutics and Thymmune Therapeutics — by email.
Frequently Asked Questions
Compare Neurona Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Neurona Therapeutics on 9 Jun 2026, and Thymmune Therapeutics on 4 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.